BiotechTube
ACI Medical

ACI Medical

San Diego, United States· Est.
acimedical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10M

Overview

ACI Medical is a private, commercial-stage medical device company focused on non-invasive vascular technologies. Its core product, the prescription ArtAssist® device, uses pneumatic compression to triple arterial blood flow in patients with peripheral arterial disease (PAD) and critical limb ischemia, aiming to promote wound healing and prevent amputations. The company has diversified into athletic recovery (FlowDyn™), diagnostic tools (APG®, VenaPulse®), and a contract manufacturing business, serving both healthcare providers and direct-to-consumer markets, including a significant partnership with the VA hospital system.

Peripheral Arterial DiseaseCritical Limb IschemiaDiabetic Foot UlcersVenous Insufficiency

Technology Platform

Platform based on controlled, rapid pneumatic compression to enhance arterial and venous blood flow, induce vascular shear stress, and stimulate physiological healing responses (vasodilation, collateral vessel formation). Applied across therapeutic (ArtAssist®, FlowDyn™) and diagnostic (APG®, VenaPulse®) devices.

Funding History

2
Total raised:$10M
Series A$8M
Seed$2M

Opportunities

The large and growing global prevalence of PAD and diabetes, coupled with an aging population, creates a significant addressable market for non-invasive limb salvage solutions.
Expansion of reimbursement coverage and deeper integration into standard wound care and vascular clinic protocols represent major growth levers.
The consumer athletic recovery market provides a parallel, less-regulated channel for revenue diversification.

Risk Factors

Key risks include dependence on the VA hospital system for a substantial portion of revenue, potential challenges in securing widespread insurance reimbursement, and competition from both established endovascular surgical procedures and other external compression devices.
The company must continuously generate robust clinical data to support adoption.

Competitive Landscape

ACI Medical competes in several spaces: for ArtAssist®, competitors include other pneumatic compression devices (e.g., devices for lymphedema, other PAD pumps), a vast array of endovascular technologies (stents, atherectomy, drug-coated balloons), and pharmaceutical therapies. In athletic recovery, it competes with other pneumatic compression boots, massage devices, and cryotherapy. Its diagnostic tools compete with other plethysmography and duplex ultrasound systems.

More companies in Regenerative Medicine →More companies in United States →